Over 115 Companies Located In Various Regions Across The Globe Claim To Provide Contract Fill / Finish Services For Various Types Of Biopharmaceutical Drug / Therapy Products, Claims Roots Analysis


Over 115 companies located in various regions across the globe claim to provide contract fill / finish services for various types of biopharmaceutical drug / therapy products, claims Roots Analysis

Despite the fact that biopharmaceuticals offer significant profit margins, innovator companies are plagued by high costs of development, complex production protocols and special procedures and equipment for fill / finish operations. Consequently, a number of drug manufacturers have demonstrated a preference for outsourcing fill / finish operations of such products.


To order this 480+ page report, which features 350+ figures and 260+ tables, please visit this link


The USD 4.2 billion (by 2030) financial opportunity within the biologics fill / finish services market has been analyzed across the following segments:

  • Types of Primary Packaging Containers
  • Ampoules
  • Cartridges
  • Syringes
  • Vials


  • Types of Biologics
  • Peptides / proteins
  • Antibodies
  • Vaccines
  • Cell therapies
  • Gene therapies
  • Viral products
  • Oligonucleotides
  • Others


  • Company Size
  • Small-sized
  • Mid-sized
  • Large / very large


  • Scale of Operation
  • Preclinical
  • Clinical
  • Commercial


  • Key Therapeutic Areas
  • Cancer
  • Infectious diseases
  • Autoimmune diseases
  • Cardiovascular diseases
  • Other indications


  • Key Geographical Regions
  • North America (US, Canada)
  • Europe (UK, France, Germany, Italy, Spain and rest of the Europe)
  • Asia-Pacific (Japan, China, South Korea, India and Australia)


The Biologics Fill / Finish Services Market, 2020-2030 report features the following companies, which we identified to be key players in this domain:

  • Advanced BioScience Laboratories (ABL)
  • Albany Molecular Research (AMRI)
  • Biocon
  • BioPharma Solutions
  • BioReliance
  • Boehringer Ingelheim BioXcellence
  • ChemPartner
  • Emergent BioSolutions
  • IDT Biologika
  • Lonza
  • LuinaBio
  • Mycenax Biotech
  • Patheon
  • Recipharm
  • Vetter Pharma
  • WuXi Biologics


Table of Contents


  1. Preface

    2. Executive Summary

  2. Introduction

  3. Competitive Landscape

  4. Company Competitiveness Analysis

  5. Biologics Fill / Finish Service Providers in North America: Company Profiles

  6. Biologics Fill / Finish Service Providers in Europe: Company Profiles

  7. Biologics Fill / Finish Service Providers in Asia-Pacific: Company Profiles

  8. Partnerships and Collaborations

  9. Recent Expansions

  10. Capacity Analysis

  11. Demand Analysis

  12. Biologics Manufacturing and Fill / Finish: Key Performance Indicator Analysis

  13. Market Sizing and Opportunity Analysis


  1. Future Growth Opportunities


  1. Case Study: Robotic Systems in Fill / Finish Operations


  1. Case Study: Ready-to-Use Packaging Components in Aseptic Fill / Finish Operations


  1. Conclusion


  1. Interview Transcripts


  1. Appendix 1: Tabulated Data


  1. Appendix 2: List of Companies and Organizations


To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/biologics-fill--finish-services-market-2019-2030/256.html


Contact Details

Gaurav Chaudhary

+1 (415) 800 3415



Keywords: roots analysis,wellness and fitness,information services,market research,research,medical devices,pharma,healthcare,pharmaceutical,active pharmaceutical ingredient,pharmaceutical product development inc


Other related blogs

The gene therapy market is estimated to be worth USD 11.6 billion in 2030, predicts Roots Analysis

By : Roots Analysis

  With multiple approved products, the field of gene therapies has gained substantial momentum..

The gene therapy market is projected to grow at an annualized rate of 45%, till 2030

By : Roots Analysis

Roots Analysis has done a detailed study on Gene Therapy Market (3rd Edition), 2019-2030, covering k..

The global digital therapeutics market is projected to be worth over USD 8.86 billion by 2030

By : Roots Analysis

Recent advances in information technology and biomedical science have enabled the development of a n..

The global digital therapeutics market is projected to be worth over USD 8.8 billion by 2030, predicts Roots Analysis

By : Roots Analysis

Roots Analysis is pleased to announce the publication of its recent study titled, “Digital Hea..